❗Final #TBJC of 2024
🕓Thurs November 28, 4pm UK
🏛️Hosts: SGUL. Chair: Sean Wasserman. Presenter: Sharenja Ratnakumar.
💊 shorturl.at/jcijg long-term efficacy & safety from STREAM2 trial of shorter regimens for #DRTB
✉️ eepurl.com/hO4D79 to join mailing list for monthly #tuberculosis journal clubs!
Thanks Verena Faehling👏 Liz Corbett & all contributors to rich discussion on tolerability, resistance, reinfection, cost-effectiveness & Bayesian meta-analysis📊
Next session: 27 March, chair: @jaseddon.bsky.social @imperialcollegeldn.bsky.social
Join mailing list: eepurl.com/hO4D79
#idsky #medsky
First TB Journal Club of 2025 meets *this Thursday* 20th at 4pm UK time 🕓
Liz Corbett & Verena Faehling @lshtm.bsky.social will be discussing shorturl.at/AGD8l Duong &al 2024 meta-analysis of VQUIN & TB-CHAMP RCTs of levofloxacin for #MDRTB contacts.
Hope to see you there!
#tbsky #tuberculosis
REMINDER - final TBJC of 2024 is tomorrow at 4pm UK time. Look forward to seeing you there!
#tuberculosis #journalclub
Kicking off #TB #JournalClub 2025 with great discussion of shorturl.at/AGD8l Duong &al 2024 meta-analysis of VQUIN & TB-CHAMP RCTs. In our closing poll, 54% of audience members would take levo TPT if their household contact had quinolone-sensitive #DRTB - the rest chose another regimen/no TPT #tbsky
Both of the bedaquiline-containing regimens maintained superiority to the control
regimen, without evidence of increased mortality, providing two additional evidence-based
treatment options for patien...
We host monthly online international journal clubs on the latest #tuberculosis literature. We welcome researchers, clinicians, and anyone else interested in #TB - eepurl.com/hO4D79 to join the mailing list & hear about future meetings.
Data from randomized trials evaluating the effectiveness of tuberculosis (TB) preventive
treatment for contacts of multidrug-resistant (MDR)-TB are lacking. Two recently published
randomized trials...
eepurl.com/hO4D79 to join mailing list - DM if you would like to join this Thursday and have not received details 🙂
The May TB Journal Club takes place *tomorrow* Thursday 29th, 4pm UK time. Liv-TB will be taking us through tinyurl.com/vn7995ke trial of pyrazinamide dosing, safety & efficacy. Look forward to seeing you there! #tuberculosis #TB
❗Final #TBJC of 2024
🕓Thurs November 28, 4pm UK
🏛️Hosts: SGUL. Chair: Sean Wasserman. Presenter: Sharenja Ratnakumar.
💊 shorturl.at/jcijg long-term efficacy & safety from STREAM2 trial of shorter regimens for #DRTB
✉️ eepurl.com/hO4D79 to join mailing list for monthly #tuberculosis journal clubs!
#Tuberculosis Journal Club
**TODAY** 4pm UK time.
@jaseddon.bsky.social & Dr Amedine Duret taking us through the drivers of adolescent TB 👫
pmc.ncbi.nlm.nih.gov/articles/PMC... by Silvia Chiang, @petedodd24.bsky.social &al
Hope to see you there!
eepurl.com/hO4D79 to join mailing list ✉️
#tbsky
Both of the bedaquiline-containing regimens maintained superiority to the control
regimen, without evidence of increased mortality, providing two additional evidence-based
treatment options for patien...
During adolescence, tuberculosis incidence rises, with a greater increase in males compared with females. Tuberculosis notifications and estimates infrequently disaggregate adolescent age groups. More...
